Scolipede #134

Market structure summary: Weekly drift is minimal (+1.3%), indicating a relatively balanced short-term market. The 90-day range spans $18.29 to $20.64 (12% spread), which indicates low-volatility behavior.

Current value is 4.1% above its 30-day reference ($18.70). Top-grade copies show substantial separation from raw: PSA 10 is pricing +456% above the current raw benchmark.

PSA 9 is currently around $18.98, while PSA 10 is $108.22.

Scolipede from Black Bolt is currently trading around $19.48. Price action is stable over 7 days, moving only +1.3%.

Against its 30-day baseline of $18.70, this card is pricing 4.1% higher. In the past 90 days, observed prices ranged from $18.29 to $20.64 (12% spread), a low-volatility profile.

This version is categorized as Illustration Rare.

In 2025, Black Bolt introduced this print of Scolipede. Card flavor text reads: "With quick movements, it chases down its foes, attacking relentlessly with its horns until it prevails." Its card type is Pokémon.

The rarity label is Illustration Rare. Printed HP is 160.

Energy typing is Darkness. Scolipede evolves from Whirlipede.

Notable ability on this print: "Poison Point". The printed attacks highlight "Venoshock".

Black Bolt entered circulation in 2025. Series classification for this set is Scarlet & Violet.

With 172 listed cards, this is a large set by modern TCG standards. As of 2026, the set is 1 year old and still in a recent release window.

Scolipede (#134) is one of the Illustration Rare prints in this expansion.

A wider Scolipede checklist helps contextualize this specific Scolipede print. This comparison sample includes 6 alternatives across 6 sets.

Observed alternatives run from $0.10 to $3.83 (3730% spread). The current card sits +2295% versus the sampled alternative average of $0.81.

Notable alternatives include Scolipede #56 (Black Bolt) at $0.21, Scolipede #53 (XY) at $0.42, Scolipede #107 (Chilling Reign) at $0.15, and Scolipede #117 (Twilight Masquerade) at $0.10.